ArticleVaccines2022

The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine.

Surakameth Mahasirimongkol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.